Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients.

[1]  J. Upham,et al.  Reduced soluble receptor for advanced glycation end-products in COPD , 2010, European Respiratory Journal.

[2]  C. Roussos,et al.  Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma. , 2010, Chest.

[3]  A. Coyle,et al.  Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[4]  Liang Dong,et al.  Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer. , 2009, Respiratory medicine.

[5]  K. Hirata,et al.  Increased levels of angiopoietin‐2 in induced sputum from smoking asthmatic patients , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  Qi Zhang,et al.  Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. , 2009, Atherosclerosis.

[7]  K. Kuwano,et al.  The role of high mobility group box1 in pulmonary fibrosis. , 2008, American journal of respiratory cell and molecular biology.

[8]  I. Pavord,et al.  Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. , 2007, Chest.

[9]  S. Peters,et al.  Neutrophils in asthma , 2007, Current allergy and asthma reports.

[10]  C. Kroegel,et al.  Krankheitskontrolle als Therapieprinzip beim Asthma bronchiale , 2007 .

[11]  I. Maruyama,et al.  Increased serum high mobility group box‐1 level in Churg–Strauss syndrome
THIS ARTICLE HAS BEEN RETRACTED , 2007, Clinical and experimental immunology.

[12]  J. Panizza,et al.  Mortality and airflow obstruction in asthma: a 17‐year follow‐up study , 2006, Internal medicine journal.

[13]  S. Holgate.  A need for circulating biomarkers of severe persistent asthma and its treatment , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  C. Lemière,et al.  Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. , 2006, The Journal of allergy and clinical immunology.

[15]  S. Holgate,et al.  The mechanisms, diagnosis, and management of severe asthma in adults , 2006, The Lancet.

[16]  M. Zorzetto,et al.  The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? , 2006, Modern Pathology.

[17]  S. Fukumoto,et al.  Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Masaki Tanaka,et al.  Contributions of high mobility group box protein in experimental and clinical acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[19]  N. Kalinina,et al.  Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines , 2004 .

[20]  K. Tracey,et al.  Extracellular role of HMGB1 in inflammation and sepsis , 2004, Journal of internal medicine.

[21]  N. Kalinina,et al.  Lesions : Role of Activated Macrophages and Cytokines Increased Expression of the DNA-Binding Cytokine HMGB 1 in Human Atherosclerotic , 2004 .

[22]  Michael Bustin,et al.  Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. , 2003, Blood.

[23]  K. Tracey,et al.  IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism1 , 2003, The Journal of Immunology.

[24]  K. Tracey,et al.  Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.

[25]  S. Takasawa,et al.  Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. , 2003, The Biochemical journal.

[26]  K. Tracey,et al.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. , 2003, Journal of immunology.

[27]  A. Ridley,et al.  Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.

[28]  P. Sterk,et al.  Sputum induction , 2002, European Respiratory Journal.

[29]  P. Jeffery.  Remodeling in asthma and chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[30]  P. Barnes,et al.  Exhaled markers of pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[31]  S. Müller,et al.  The High Mobility Group (Hmg) Boxes of the Nuclear Protein Hmg1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells , 2001, The Journal of cell biology.

[32]  H. Huttunen,et al.  Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) Activation* , 2000, The Journal of Biological Chemistry.

[33]  K. Tracey,et al.  Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. , 1999, Surgery.

[34]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[35]  M. Rocchi,et al.  The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. , 1996, Genomics.

[36]  J. Chen,et al.  The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.

[37]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[38]  Y. Zou,et al.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.

[39]  W. Hurley,et al.  Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. , 1992, The Journal of biological chemistry.

[40]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[41]  G. Reeck,et al.  A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. , 1989, Nucleic acids research.